The venous thrombosis registry in Østfold Hospital (TROLL registry) ‐ design and cohort description

Abstract

Purpose:The incidence of venous thromboembolism (VTE) is expected to increase over the next decades, further increasing its substantial impact on patients and health care resources. Registries have the benefit of reporting real-world data without excluding clinically important subgroups. Our aim was to describe a Norwegian VTE registry and to provide descriptive data on the population and management. Registry Population:The Venous Thrombosis Registry in Østfold Hospital (TROLL) is an ongoing registry of consecutive patients diagnosed with, treated, and/or followed up for VTE at Østfold Hospital, Norway, since 2005. Baseline and follow-up data, including demographics, clinical features, risk factors, diagnostic procedures, classification of VTE, and treatment were collected during hospitalization, and at scheduled outpatient visits.

Safety and effectiveness of rehabilitation training for stroke complicated with muscular call vein thrombosis: An observational study

“…[18] Moreover, a previous study [19] in similar patients who received a full dose of low molecular weight heparin and a preliminary report on a randomized trial, showed that heparin at a therapeutic dose for 2 to 6 weeks was an effective and safe alternative to warfarin in patients with MCVT. [20] The results suggest the safety of the treatment protocol in all the patients, and during follow up, no major bleeding was observed.…”

Anticoagulation in Patients with Isolated Distal Deep Vein Thrombosis: Bringing the Puzzle Together

“…In a recent study of 475 patients with non-cancer-associated IDDVT, the cumulative incidence of recurrent VTE after anticoagulation cessation (median treatment duration: 92 days) was 5.6, 14.7, and 27.2% at 1, 5, and 10 years, respectively. 14 In the same study, the 3-month incidence of major bleeds in anticoagulant-treated patients was 1.5%, and 0.8% when considering DOAC users only. 14…”

Incidence and Clinical Features of Venous Thromboembolism in Inpatients with Mental Illness

“…[13][14][15] In contrast, some studies have reported no sex-based differences in VTE incidence. [16][17][18] However, a cohort study also observed an increased risk of the first VTE event in men compared with women. 19 The results of these studies are difficult to interpret owing to differences in methods used and insufficient sample sizes to allow separate investigation of men and women, which may be associated with the inclusion of male and female populations.…”

“…The most common comorbidities included hypertension (26.92%), stroke (14.10%), and diabetes (12.82%). In terms of hospitalization, there was no statistical difference in length of stay between the VTE and non-VTE groups (21 [13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30] day vs. 19 [13][14][15][16][17][18][19][20][21][22][23][24][25][26][27] day, P = 0.340). The VTE events occurred in 4 (2-7)day of hospitalization.…”